First human trial marks a strategic inflection point in Nipah vaccine readiness
A novel experimental vaccine against the nipah virus has succeeded in its first major test in humans; it has been shown to be tolerated well by the immune system and to stimulate an immune response in healthy adults. Though this is the earliest stages of testing, there’s tentative hope that more robust shielding will be…